repaglinide

Generic: repaglinide

Labeler: american health packaging
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name repaglinide
Generic Name repaglinide
Labeler american health packaging
Dosage Form TABLET
Routes
ORAL
Active Ingredients

repaglinide 1 mg/1

Manufacturer
American Health Packaging

Identifiers & Regulatory

Product NDC 60687-560
Product ID 60687-560_2517f71f-f461-1f56-e063-6394a90a6ef1
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203820
Listing Expiration 2026-12-31
Marketing Start 2020-09-17

Pharmacologic Class

Established (EPC)
glinide [epc]
Mechanism of Action
potassium channel antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 60687560
Hyphenated Format 60687-560

Supplemental Identifiers

RxCUI
200256
UNII
668Z8C33LU
NUI
N0000175428 N0000175448

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name repaglinide (source: ndc)
Generic Name repaglinide (source: ndc)
Application Number ANDA203820 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1 mg/1
source: ndc
Packaging
  • 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-560-21) / 1 TABLET in 1 BLISTER PACK (60687-560-11)
source: ndc

Packages (1)

60687-560-21 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-560-21) / 1 TABLET in 1 BLISTER PACK (60687-560-11)

Ingredients (1)

repaglinide (1 mg/1)

Linked Drug Pages (1)

Repaglinide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2517f71f-f461-1f56-e063-6394a90a6ef1", "openfda": {"nui": ["N0000175428", "N0000175448"], "unii": ["668Z8C33LU"], "rxcui": ["200256"], "spl_set_id": ["dd1d8337-9903-4b8a-a9ea-569e4d134e74"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-560-21)  / 1 TABLET in 1 BLISTER PACK (60687-560-11)", "package_ndc": "60687-560-21", "marketing_start_date": "20200917"}], "brand_name": "Repaglinide", "product_id": "60687-560_2517f71f-f461-1f56-e063-6394a90a6ef1", "dosage_form": "TABLET", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "60687-560", "generic_name": "Repaglinide", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Repaglinide", "active_ingredients": [{"name": "REPAGLINIDE", "strength": "1 mg/1"}], "application_number": "ANDA203820", "marketing_category": "ANDA", "marketing_start_date": "20200917", "listing_expiration_date": "20261231"}